Recurrence Common in ILD Related to Antisynthetase Syndrome

Medication reduction may trigger recurrence in interstitial lung disease related to antisynthetase syndrome. In 132 patients, the recurrence rate was 52.3%; the median time from treatment initiation to recurrence was 11 months. Recurrence often occurred with medication intensity reduction.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ